Lentiviral vector integration sites in human NOD/SCID repopulating cells
- 8 September 2006
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 8 (10) , 1197-1207
- https://doi.org/10.1002/jgm.958
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trialBlood, 2005
- Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor CellsPLoS Biology, 2004
- Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site PreferencesPLoS Biology, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Molecular Evidence of Lentiviral Vector-Mediated Gene Transfer into Human Self-Renewing, Multi-potent, Long-Term NOD/SCID Repopulating Hematopoietic CellsMolecular Therapy, 2002
- HIV-1 Integration in the Human Genome Favors Active Genes and Local HotspotsCell, 2002
- MUF1, A Novel Elongin BC-interacting Leucine-rich Repeat Protein That Can Assemble with Cul5 and Rbx1 to Reconstitute a Ubiquitin LigasePublished by Elsevier ,2001
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994